Position in EOLS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,228,429
+$2,112,929 QoQ
Shares Held
2,245,360
+109.8% QoQ
Ownership
3.41%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $344,937,665 across 8 Drug Manufacturers - Specialty & Generic names. EOLS ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
187,187 | $110,998,147 | |
| 2 | ALKS |
Alkermes plc.
|
1,970,864 | $69,689,751 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
820,243 | $63,076,686 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,274,000 | $38,831,520 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
521,353 | $25,103,146 | |
| 6 | ORGO |
Organogenesis Holdings Inc.
|
10,085,951 | $23,903,703 | |
| 7 | EOLS |
Evolus, Inc.
This page
|
2,245,360 | $9,228,429 | |
| 8 | ETON |
Eton Pharmaceuticals, Inc.
|
166,381 | $4,106,283 |
All Filings in EOLS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,228,429 | 2,245,360 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,115,500 | 1,070,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $8,903,000 | 1,450,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,515,990 | 2,119,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $12,982,270 | 1,079,158 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,696,624 | 697,158 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,810,416 | 1,037,680 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,499,200 | 1,152,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,240,000 | 160,000 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $18,992,920 | 2,078,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,393,590 | 1,017,000 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $9,403,841 | 810,676 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,353,324 | 1,368,389 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,195,367 | 1,258,889 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,899,157 | 642,934 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,337,000 | 580,000 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||